• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7311
Device Problem Unsealed Device Packaging (1444)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/21/2019
Event Type  malfunction  
Manufacturer Narrative
The patient/family was the initial reporter, so personal information was not entered.No information was captured as the customer's weight was not provided.The customer did not return the suspected product.The cause of the cap of the test strips bottle being open is unknown.
 
Event Description
The customer reported that she opened a box of contour next test strips and found the bottle of strips was already open.There was no allegation of an adverse event.The customer was advised to return the test strips for evaluation.Replacement test strips were sent to the customer.
 
Manufacturer Narrative
The customer did not return the suspected product.A device history record was reviewed for the contour next test strips lot # 8hpef02 and no manufacturing anomalies were found.The retention samples were verified to have 50 strips each in 10 bottles.An investigation was performed to verify the appearance of bottles with sampling of 5 bottles every batch.No defects for open caps were found since the start of contour next production.
 
Manufacturer Narrative
The customer returned contour next test strips lot # 8hpeg02a, which was different from lot # 8hpef02a indicated to be involved in the event.An in-house testing was performed using the in-house contour next meter with in-house contour next control solution and returned test strips, which gave satisfactory performance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Type of Device
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
MDR Report Key8792576
MDR Text Key151117502
Report Number1810909-2019-00300
Device Sequence Number1
Product Code NBW
UDI-Device Identifier10301937311502
UDI-Public10301937311502
Combination Product (y/n)N
PMA/PMN Number
K111268
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Remedial Action Replace
Type of Report Initial,Followup,Followup
Report Date 06/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/16/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/31/2020
Device Model Number7311
Device Catalogue Number7311
Device Lot Number8HPEF02A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/20/2019
Date Manufacturer Received08/20/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age73 YR
-
-